Veradigm | MDRX - Debt


Veradigm reported $200.33M in Debt for its fiscal quarter ending in September of 2022.





Debt Change Date
Alcidion AUD 1.37M 329K Dec/2024
Ambu A/S DKK 551M 6M Mar/2026
Amplifon EUR 1.82B 10.94M Dec/2025
Cardinal Health USD 8.92B 111M Mar/2026
Centene USD 16.37B 1.79B Mar/2026
Charles River Laboratories USD 2.57B 58.23M Dec/2025
Cigna USD 30.9B 563M Mar/2026
Coloplast 18.67B 35M Sep/2023
Computer Programs Systems USD 141.89M 2.67M Sep/2023
Convatec Group USD 1.2B 210.3M Dec/2024
CVS Health USD 78.34B 13.78B Mar/2026
Diasorin EUR 769.18M 97.18M Jun/2025
Elevance Health USD 31.84B 204M Mar/2026
General Electric Aerospace USD 20.28B 217M Mar/2026
Gulf Medical Proj AED 7.67M 1.75M Mar/2025
Humana USD 13.99B 1.62B Mar/2026
IQVIA Holdings USD 15.83B 109M Mar/2026
Laboratory Of America USD 6.53B 3.9M Dec/2025
Maximus USD 1.67B 226.1M Dec/2025
McKesson USD 8.62B 1.17B Dec/2025
Med Life RON 1.94B 52.08M Sep/2025
Molina Healthcare USD 3.95B 3M Mar/2026
Omnicell USD 204.34M 2.44M Dec/2025
Oriola-kd EUR 76.1M 13M Dec/2024
Owens Minor USD 1.95B 91.18M Mar/2025
Quest Diagnostics USD 6.41B 179M Mar/2026
Rede D'or Sao Luiz BRL 52.46B 2.5B Mar/2026
Siemens Healthineers EUR 764M 8M Dec/2025
Sonova Holding CHF 1.91B 130.9M Jun/2023
Supermax Corporation Bhd MYR 164.16M 15.6M Sep/2025
UnitedHealth USD 77.92B 472M Mar/2026
Veeva Systems USD 89.8M 4.35M Sep/2025
Veradigm USD 200.33M 431K Sep/2022
Xerox USD 3.3B 101M Mar/2025